Navigation Links
UW-Madison rat experiment could lead to stem-cell treatment for ALS

Madison, Wis. Scientists at the University of Wisconsin-Madison have sucessfully injected stem cells into rats' spines in a way that could lead to treatments for degenerative diseases but they did not use the controversial embryonic stem cells.

The researchers inserted human stem cells derived from fetal brain tissue into the spinal cords of rats afflicted with ALS, a disease tha......

Full article >>> ke embryonic stem cells, they can grow without animal derivatives that are considered a potential source of contamination, Svendsen said.

"This is the first study that shows that certain types of stem cells can survive and release powerful protective proteins in the spinal cord of rats with a genetic form of ALS," Svendsen said in a release.

Once inside the brain or spinal cord, ......

Full article >>> gnosed with ALS. The disease attacks nerve cells in the brain and spinal cord; as motor neurons progressively die, the brain cannot initiate and control muscle movement.

The UW-Madison researchers tackled several technical barriers trying to ensure that the progenitor cells correctly gathered near the motor neurons in the spinal cord while continuing to pump GDNF once they got there, said......

Full article >>> vendsen is consulting with the Food and Drug Administration on what needs to be done to go ahead with human trials. The team should be able to put cells into human patients within two to three years, she said.

Ordinarily, the researchers would first test the work in primates. However, "it's such a horrible disease that it's unethical for primates to be given this disease," Klein told WTN.......

Full article >>>
'"/>

Source:wistechnology.com By Lincoln Brunner 04/20/05


Related biology technology :

1. UW-Madison to receive $125M for bioenergy research center
2. Three finalists named for UW-Madison CIO
3. UW-Madison launches new high-speed research network
4. UW-Madison approves new research institute
5. UW-Madison dean predicts bio-economy will fuel Wisconsin
6. Scott Converse, UW-Madison School of Business, on the innovation mind-set
7. Scott Converse, UW-Madison School of Business, on IT workforce development
8. UW-Madisons Beebe wins scientific award
9. UW-Madison MBA program ranked among best for investment return
10. UW-Madison gets $333,000 for biofuels research
11. UW-Madison enters Kauffman grant competition
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2017)... ... April 25, 2017 , ... LABS, Inc. (LABS) announced in December 2016 that ... test menu: Nucleic Acid Testing (NAT) for ZIKV; and Enzyme Immunoassays (EIAs) specific for ... NAT screening for blood donors under an Investigational New Drug (IND) study protocol. ...
(Date:4/25/2017)... ... ... As part of the Stago EdVantage Virtual University Virtual Event, ... order to illuminate this clinical problem for people unfamiliar with the topic. , DIC ... high degree of morbidity and mortality. DIC is a confusing disorder from both diagnostic ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... Metrology Partners.     , Covalent’s Analytical Services unit provides high-quality data to ... measured within 24 hours of receipt. There are no price premiums, and customers ...
(Date:4/21/2017)... ... ... Having worked on the design of the innovative Triton™ lab bench ... lab design architects from around the country at the Lab Design Conference 2017 in ... Greg Casey will be at the show, where they will highlight the unique elements ...
Breaking Biology Technology:
(Date:4/13/2017)... -- According to a new market research report "Consumer IAM ... and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - Global ... grow from USD 14.30 Billion in 2017 to USD 31.75 Billion by ... ... MarketsandMarkets Logo ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
Breaking Biology News(10 mins):